FDA Clears Emerging AI-Enabled Platform for Intravascular Ultrasound

The Food and Drug Administration (FDA) has issued 510(k) clearance for the Evident Vascular Guidance System and Evident peripheral imaging catheters.

Emphasizing high-fidelity images for intravascular ultrasound (IVUS), the Evident Vascular Guidance System combines broad frequency bandwidth with an enhanced transducer design and advanced signal processing, according to Evident Vascular, the manufacturer of the Evident Vascular Guidance System.

“The vessel-edge clarity and consistency across the field of view are remarkable. By optimizing resolution and penetration across a range of vessel sizes and imaging depths, Evident’s technology provides detailed images for physicians to consider when measuring vessels, making decisions about therapy, and assessing procedural results,” said Eric A. Secemsky, MD, the director of vascular intervention at Beth Israel Deaconess Medical Center.

Evident Vascular added that the IVUS platform facilitates improved efficiency for peripheral vascular interventions via an intuitive user interface, flush-less plug-and-play catheters and hands-free voice control.